51P Efficacy of PARP inhibitors in patients with advanced high grade serous ovarian cancer according to BRCA domain mutations

Autor: Buonaiuto, R., Neola, G., Parola, S., Cefaliello, A., Pecoraro, G., Grieco, A., Flauto, F., Amato, A.R., Lamia, M.R., Salomone, F., Caltavituro, A., Pepe, F., Malapelle, U., Ventriglia, J., Pignata, S., De Angelis, C.
Zdroj: In ESMO Open February 2023 8(1) Supplement 1
Databáze: ScienceDirect